In a mouse model, SIRT6 alleviated liver fibrosis by the deacetylation of Smad2, inhibited the TGF-β-induced phosphorylation and nuclear localization of Smad2, and decreased the transcription of TGF-β/Smad2 signaling [48]. Here, SMAD2 is linked to Hepatic fibrosis.